AHA Comments on CMS 340B Hospital Survey Notice

The AHA today submitted comments to Centers for Medicare & Medicaid Services Administrator Seema Verma regarding the CMS' notice to undertake a survey of hospitals participating in the 340B Drug Pricing Program to collect actual acquisition costs for specified covered outpatient drugs.

Key Resources

Related Resources

Letter/Comment
AHA Responds to Senate RFI on the SUSTAIN 340B Act Draft
AHA Center for Health Innovation Market Scan
Virtual Care Platform Wheel Expands Its Services, Focusing on Convenience
Public
Guides/Reports
The 340B Drug Pricing Program
Advisory
Senators Release 340B Discussion Draft & RFI
Member
Testimony
AHA Statement on “Health Care Spending in the United States: Unsustainable for Patients, Employers, and Taxpayers”
Public
AHA Center for Health Innovation Market Scan
Cost-Plus Drug Pricing Models Gain Momentum, but Will They Last?